Remus Pharmaceuticals P/B Ratio
Current P/B Ratio
2.48
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Remus Pharmaceuticals (REMUS) P/B ratio is 2.48 (Moderate), book value per share ₹292.50 vs Healthcare average P/B of -0.31 — High - Premium to book value, growth expectations or asset-light model. View Remus Pharmaceuticals 52-week for the annual high/low range and current price position.
Current Valuation Metrics
P/B Ratio
2.48
Current Price
₹
Book Value/Share
₹292.50
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹351 Cr
Share Capital
₹12 Cr
Reserves & Surplus
₹339 Cr
Outstanding Shares
12,000,000
Book Value per Share
₹292.50
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.31
Sector Median
0.57
Sector Rank
#11 of 50
Sector Percentile
22.0%
REMUS P/B Ratio — Valuation Insights & Book Value Analysis
Remus Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 2.48 (Moderate). Review REMUS P/E comparison to evaluate earnings-based valuation against sector peers.
- Trading at premium to sector average PB of -0.31
REMUS vs Healthcare Peers — P/B Ratio Comparison
Remus Pharmaceuticals P/B 2.48 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
Sector Average
-0.31
Sector Median
0.57
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |